Moolec Science S.A. (MLEC)
Moolec Science S.A. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Moolec Science S.A. (MLEC) is a Biotechnology company based in LU with a market capitalization of $6.1M. Revenue grew 5830.7% year-over-year and free cash flow was negative at -$30.1M. This page tracks MLEC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
LU · 52 employees · IPO Mar 2, 2021
Valuation
Valuation & price
$8.93as of May 17, 2026· -82.2% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
—
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$6.1M
Market cap
5830.7%
Revenue growth (YoY)
34.2%
Gross margin
-$30.1M
Free cash flow (USD)
$237.9M
Net debt
-83.2%
Share dilution
0/4
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2021 → 2025
Free cash flow by year
2021 → 2025
Gross margin by year
2023 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: May 14, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 6-K filingJul 13, 2026Filing
Winding Up Petition Received
- 6-K filingJun 2, 2026Filing
Regulatory Update
- Annual reportMay 14, 2026Filing
Annual Report Filed
- Annual reportMay 14, 2026Filing
Annual Report Filed
- Quarterly reportMay 13, 2026Filing
Half-Year Report Filed
- 6-K filingApr 15, 2026Filing
Annual General Meeting Notice
- 6-K filingApr 2, 2026Filing
New Controlling Shareholder
Questions
Frequently asked questions
What is Moolec Science S.A.'s market cap?
Moolec Science S.A. (MLEC) has a market capitalization of $6.1M.
What is MLEC's P/E ratio?
A meaningful P/E ratio is not available for MLEC — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
When did Moolec Science S.A. last report earnings?
MLEC last reported earnings on May 14, 2026; the next date is not yet scheduled.
Are insiders buying MLEC stock?
SEC Form 4 filings show no open-market insider buys at Moolec Science S.A. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.